DF-1283

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameDF-1283
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsEmphysemaRespiratory Distress Syndrome, AdultCystic Fibrosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDompe Farmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDompe Farmaceutici Spa
Active IndicationsN/A
Inactive IndicationsEmphysemaRespiratory Distress Syndrome, AdultCystic Fibrosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A